openPR Logo
Press release

Global Monoclonal Antibody Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020

05-10-2021 10:12 AM CET | Health & Medicine

Press release from: Credible Markets

Monoclonal Antibody Industry Market

Monoclonal Antibody Industry Market

Growing research and development activities in the field of genomics complemented by the advent of technologically robust genetic platforms such as NGS (Next Generation Sequencing) continue to influence the global monoclonal antibody market. This factor coupled with cost-efficient characteristic of the next generation sequencing and other technologies has proven vital in their incorporation in analyzing and performing deep research to develop monoclonal antibodies (mABS). These widely accepted biologics are expected to present huge opportunities to manufacturers in the pharmaceutical domain to develop novel drugs for chronic disorders.

In addition to biologics of monoclonal antibody, increasing awareness among physicians and patients alike with respect to potential uses of monoclonal antibody therapies are expected to pave new avenues of growth for the monoclonal antibody market worldwide. Moreover, approval of use of monoclonal antibodies in drugs to treat various indications is expected to create a surge in demand for monoclonal antibodies in turn triggering their market’s growth. For example, drugs such as Herceptin, Avastin, Rituxan, and Remicade that have FDA approval for use across an array of conditions including but not limited to cancer, arthritis and ulcerative colitis have not only generated higher revenues but also created a massive patient pool. This aspect continues to fuel the use of monoclonal antibody in drug development for treating various chronic disorders, consequently supporting the growth of the global monoclonal antibody market.

Download FREE Sample Copy of Monoclonal Antibody Market Report @ https://www.crediblemarkets.com/sample-request/monoclonal-antibody-industry-market-916764

Global Monoclonal Antibody Market: By Types
In Vivo
In Vitro

Global Monoclonal Antibody Market: By Applications
Cancer
Autoimmune Diseases
Inflammatory Diseases
Infectious Diseases
Microbial Diseases
Others

Global Monoclonal Antibody Market: Key Players
AbbVie
Spectrum Pharmaceuticals
Novartis
AstraZeneca
Amgen
Seattle Genetics
Biogen Idec
Johnson & Johnson
Bristol-Myers Squibb
Alexion Pharmaceuticals
Genentech
Merck
Lonza
Roche Pharmaceuticals
Sanofi
Lilly
UCB

Global Monoclonal Antibody Market: Regions
• North America (United States, Canada and Mexico)
• Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
• Asia Pacific (China, Japan, India, Southeast Asia and Australia)
• Latin America (Brazil, Argentina and Colombia)
• Middle East and Africa

Direct Purchase Monoclonal Antibody Market Research Report Now @ https://www.crediblemarkets.com/reports/purchase/monoclonal-antibody-industry-market-916764?utf8=%E2%9C%93&license_type=single_user

Humanized Monoclonal Antibody Likely To Maintain Its Strong Status Quo In The Market
The demand for humanized monoclonal antibody is expected to witness moderate growth in the years to follow. However, the market valuation for humanized monoclonal antibody is estimated to account for a major share in the global monoclonal antibody market. This is mainly attributed toward use of humanized monoclonal antibodies in treating various disorders such as inflammatory diseases, autoimmune diseases and mainly cancer. The growth in the market scenario of humanized monoclonal antibody is also complemented by the application of advanced technologies such as transgenic mice and yeast display for their development.

North America To Dominate The Monoclonal Antibody Market Followed By European And Asian Countries
The monoclonal antibody market in North America, particularly in the United States is estimated to account for a major share in the global marketplace. Increasing cancer incidences in the country, coupled with favourable government support to healthcare facilities and favourable funding are few of the factors influencing the use of novel therapies in treating chronic conditions and use of mABS is no exception. On the other hand, the monoclonal antibody demand is expected to increase across various Asian countries, mainly due to rising lifestyle diseases coupled with increasing population. Emerging countries such as China and India are likely to contribute to the growing demand for use of monoclonal antibody in drug development to fight various lifestyle diseases.

Alternative Treatments To Emboss A Negative Impact On The Monoclonal Antibody Market
Natural remedies and alternative treatments are gaining steam across the globe on the back of slow yet effective and promising results, convenience in use and dosage and relatively cheaper pricing. On-going advances in the treatments across various domains such as Ayurveda and Homeopathy and acceptance of yoga sujok and acupuncture therapies are gaining popularity. The revenue generated by these therapies is also rising, yet at a moderate pace, however impacting the use of monoclonal antibody in drugs, subsequently impacting their sales. For instance, in 2017 the retail sales of herbal and homeopathy medicines in the US were around USD 7 billion. Likewise, traditional market valuation increased by USD 161 billion to touch USD 360 billion in 2017 from 2015 in the country. Less expensive nature of the alternate remedies is expected to fuel their demand exerting a negative influence on the global monoclonal antibody market.

COVID 19 Can Be Neutralized Using Monoclonal Antibody, Either By Combination Or Alone
The COVID 19 pandemic, albeit its negative impact on various markets, is expected to present potential avenues to manufacturers of monoclonal antibody. This is directly related to the efficiency of monoclonal antibody in fighting against COVID virus as monoclonal antibody, either in combination with or alone has the potential to treat and/or prevent COVID 19. Scientists predict that the use of monoclonal antibody in making drugs for COVID 19 can also be extended to future emerging diseases caused in humans by viruses from Sarbecovirus subgenus. Against this backdrop, pharmaceutical companies have started development and testing of novel drugs made from monoclonal antibody to treat COVID 19. For instance, Astrazeneca is planning to start phase 1 trial of monoclonal antibody therapy to treat COVID in the second quarter of 2020. The pharmaceutical giant stresses on the fact that the combination of two monoclonal antibodies could be a single effective preventive therapy against the virus by performing a neutralizing effect.

Do You Have Any Query or Specific Requirement? Ask to Our Industry Expert @ https://www.crediblemarkets.com/enquire-request/monoclonal-antibody-industry-market-916764

The report can answer the following questions:
• North America, Europe, Asia Pacific, Middle East & Africa, Latin America market size (sales, revenue and growth rate) of Monoclonal Antibody industry.
• Global major manufacturers’ operating situation (sales, revenue, growth rate and gross margin) of Monoclonal Antibody industry.
• Global major countries (United States, Canada, Germany, France, UK, Italy, Russia, Spain, China, Japan, Korea, India, Australia, New Zealand, Southeast Asia, Middle East, Africa, Mexico, Brazil, C. America, Chile, Peru, Colombia) market size (sales, revenue and growth rate) of Monoclonal Antibody industry.
• Different types and applications of Monoclonal Antibody industry, market share of each type and application by revenue.
• Global market size (sales, revenue) forecast by regions and countries from 2019 to 2026 of Monoclonal Antibody industry.
• Upstream raw materials and Monoclonal Antibody equipment, industry chain analysis of Monoclonal Antibody industry.
• SWOT analysis of Monoclonal Antibody industry.
• New Project Investment Feasibility Analysis of Monoclonal Antibody industry.

Read More: https://crediblemarkets.com/press-releases/pervasiveness-of-research-and-development-to-complement-growth-of-the-global-monoclonal-antibody-market

Contact Us
Credible Markets Analytics
99 Wall Street 2124 New York, NY 10005
Email: sales@crediblemarkets.com

About US
Credible Markets has emerged as a dependable source for the market research needs of businesses within a quick time span. We have collaborated with leading publishers of market intelligence and the coverage of our reports reserve spans all the key industry verticals and thousands of micro markets. The massive repository allows our clients to pick from recently published reports from a range of publishers that also provide extensive regional and country-wise analysis. Moreover, pre-booked research reports are among our top offerings.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Monoclonal Antibody Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020 here

News-ID: 2282156 • Views:

More Releases from Credible Markets

Omega 3 Market Scope, Size, Types, Applications, Industry Trends, Drivers, Restraints, and Expansion Plans & Forecast to 2030
Omega 3 Market Scope, Size, Types, Applications, Industry Trends, Drivers, Restr …
The Omega-3 Market was Worth USD 1812 Million in 2021 and is Predicted to Reach USD 4215.7 Million by 2028, Rising at a CAGR of 12.82 Percent between 2021 and 2028. Omega-3 is a type of fat that is beneficial to one's health and is classified into three types: alpha-linolenic acid, docosahexaenoic acid, and eicosapentaenoic acid. Because the human body is unable to produce alpha-linolenic acid (ALA), it must be ingested,
Telehandler Market Objectives of the Study Includes Research Methodology and Assumptions and Forecast by 2030
Telehandler Market Objectives of the Study Includes Research Methodology and Ass …
In accordance to the research report by Credible Markets Telehandler Market Telehandler market exhibited a modest growth of 5.4% in 2020. It is projected to grow from USD 6.19 billion in 2021 to USD 9.38 billion in 2028 at a CAGR of 6.1% in the 2021-2028 period. Telehandlers Market Overview The telehandlers are the items that are utilized in lifting and moving weighty materials like cases, holder merchandise and other weighty items.
Keyless Vehicle Access Control Systems Market Key Drivers & On-Going Trends 2020 to 2030
Keyless Vehicle Access Control Systems Market Key Drivers & On-Going Trends 2020 …
In accordance to the research report by Credible Markets, Keyless Vehicle Access Control Systems Market was valued at $1.72 billion in 2021, and is projected to reach $5.36 billion by 2031, registering a CAGR of 12.8% during the forecast period 2022-2030. Keyless Vehicle Access Control Systems Market -Market Overview: A keyless vehicle access control framework depends on an electronically worked locking component to tie down admittance to a vehicle. It has sending
Pharmaceutical Intermediates Market Industry Growth Analysis on Latest Trends and Forecast by 2030
Pharmaceutical Intermediates Market Industry Growth Analysis on Latest Trends an …
Pharmaceutical intermediates are chemical compounds that are widely used in the manufacture of various types of drugs in large quantities and are also used by pharmaceutical and biopharmaceutical companies for research and development. Pharmaceutical intermediate products are used as raw materials in the manufacture of bulk drugs. Leading biopharmaceutical and pharmaceutical manufacturing companies are focused on increasing their product range worldwide. These companies focus on improving their product offerings in

All 5 Releases


More Releases for Monoclonal

Impact COVID-19 on Monoclonal Antibodies Market 2021 Generated Opportunities for …
Different monoclonal antibodies with unique mechanism of actions have been approved over the past few years, which work on immune checkpoints such as CTLA-4, PD-1, and PD-L1. Manufacturers are focusing on developing drugs belonging to various classes in order to treat variety of diseases ranging from cancer to rare diseases. Monoclonal antibody coupled with chemotherapy agents is becoming a viable treatment option to treat various cancers. For instance, in 2017,
Monoclonal Antibodies Market Outline and Updates..!!
Rising adoption of strategies such as acquisition, collaboration, and license agreement by the market players is expected to bolster the monoclonal antibodies market growth over the forecast period. For instance, in 2018, F. Hoffman-La Roche AG and Kymab Group Ltd entered into a clinical trial agreement to evaluate KY1044 (product of Kymab Group), a human monoclonal antibody, for the treatment of solid tumors. Also, in 2018, Novartis AG entered into
Global Monoclonal Antibody Diagnostic Reagents Market
Antibodies are an essential tool for many applications including flow cytometric analysis, immunoprecipitation, enzyme-linked immunosorbent assay (ELISA), immunocytochemistry, western blotting, and immunohistochemistry. Moreover, monoclonal antibodies (MAbs) are significant diagnostic reagent used in microbiological research, biomedical research, and also in diagnosis of various diseases such as HIV, hepatitis, herpes simplex, influenza infections, chlamydia, as well as for the treatment of cancer. Therefore, due to its importance in the clinical application, it
Monoclonal Antibody Custom Service Market Ravishing Growth with CAGR of 10.84% | …
Complete Study of Monoclonal Antibody Custom Service Market Research Report is added on MarketResearchFuture.com with Latest Advancement. Detail analysis on possible segments and sub segments of the market. Along with this regional analysis of the market which includes North America, Europe, Asia Pacific and Middle East and Africa. Avail Premium Sample Copy @ https://www.marketresearchfuture.com/sample_request/4515 Monoclonal Antibody Custom Service Market – Overview It is estimated that monoclonal antibody custom service market is expected to
Global Monoclonal Antibodies Pipeline Analysis
The market for monoclonal antibodies (mAB) has become the fastest growing segment of the pharmaceutical industry. In 2012, there were more than 30 monoclonal antibody therapies approved by the FDA which generated annual sales of more than US$ 40 Billion. As the therapeutic mABs already play a significant part in effective medical treatment, it is most likely that their importance would increase by manyfolds in the future. There has been a
Global Cancer Monoclonal Antibodies Pipeline Analysis
In the past few years monoclonal antibodies have emerged as a therapeutic modality for cancer. These monoclonal antibodies are designed to selectively target cancer cells and extract various responses, thus indirectly protecting the non cancerous cells. This characteristic of monoclonal antibodies coupled with increasing potential of the oncology market has made many pharmaceutical giants to invest a significant portion of their R&D on cancer monoclonal antibodies. In recent years the popularity